Antidepressants are medications that alleviate symptoms of major depressive disorder and other mood and anxiety conditions through modulation of monoamine neurotransmitter systems. The monoamine hypothesis, which proposes that depression results from deficient serotonin, norepinephrine, or dopamine signaling, has guided the development of multiple antidepressant classes with distinct pharmacological profiles.
What Are Antidepressants?
Major depressive disorder affects millions worldwide and is a leading cause of disability. Antidepressants form the pharmacological cornerstone of its management, though their therapeutic effects take weeks to emerge despite rapid neurotransmitter modulation. This delay suggests that neuroplastic changes, including increased brain-derived neurotrophic factor and synaptic remodeling, are essential for the antidepressant response beyond acute neurotransmitter elevation.
Mechanism of Action
Selective serotonin reuptake inhibitors such as fluoxetine, sertraline, and escitalopram block the serotonin transporter, increasing synaptic serotonin levels. They are first-line antidepressants due to their favorable safety profile and tolerability. SSRIs have minimal effects on norepinephrine or dopamine and are generally safer in overdose than older antidepressants.
Serotonin-norepinephrine reuptake inhibitors such as venlafaxine, duloxetine, and desvenlafaxine block both serotonin and norepinephrine transporters. The dual mechanism may provide greater efficacy for some patients, particularly those with pain-predominant or energy-predominant symptoms. Venlafaxine exhibits dose-dependent norepinephrine reuptake inhibition, becoming more noradrenergic at higher doses.
Tricyclic antidepressants such as amitriptyline and nortriptyline block serotonin and norepinephrine reuptake but also antagonize histamine H1, muscarinic, and alpha-1 adrenergic receptors, resulting in sedation, anticholinergic effects, and orthostatic hypotension. TCAs are effective but are reserved for second-line use due to their toxicity in overdose and adverse effect burden.
Monoamine oxidase inhibitors such as phenelzine inhibit the enzyme that degrades monoamines, increasing serotonin, norepinephrine, and dopamine levels. They are highly effective but require dietary restrictions to avoid hypertensive crisis from tyramine ingestion and have numerous drug interactions.
Atypical antidepressants include bupropion, which inhibits dopamine and norepinephrine reuptake without significant serotonergic effects, and mirtazapine, which enhances norepinephrine and serotonin release through presynaptic alpha-2 receptor antagonism. These agents provide alternatives for patients who do not respond to or cannot tolerate first-line therapies.
Therapeutic Uses
Antidepressants are indicated for major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder. They are also used for chronic pain conditions such as neuropathic pain and fibromyalgia, and for bulimia nervosa.
Adverse Effects
SSRIs commonly cause gastrointestinal upset, sexual dysfunction, insomnia or sedation, and weight gain. Serotonin syndrome, a potentially life-threatening condition of excessive serotonergic activity, can occur with high doses or combinations of serotonergic drugs. SNRI adverse effects include hypertension, particularly at higher doses of venlafaxine, and a discontinuation syndrome with abrupt cessation. TCAs cause anticholinergic effects, sedation, weight gain, and cardiotoxicity in overdose. MAOIs require dietary restrictions and carry risks of hypertensive crisis.
Contraindications
Caution is required when switching antidepressants due to washout periods, particularly involving MAOIs. SSRIs and SNRIs should be used cautiously in patients with bipolar disorder due to risk of manic switch. TCAs are relatively contraindicated in patients with heart block or recent myocardial infarction. MAOIs are contraindicated with tyramine-rich foods and numerous interacting medications.
Conclusion
Antidepressants provide effective treatment for depressive and anxiety disorders, with multiple classes available to individualize therapy. The selection of an antidepressant is guided by symptom profile, adverse effect considerations, comorbid conditions, and patient preference.
